Drugs / Intranasal Influenza Live Attenuated Vaccine
Intranasal Influenza Live Attenuated Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06609811 | Sep → Dec 2024 | influenza | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intranasal Influenza Live Attenuated Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06609811 ↗ |
| Modality | Vaccine | “intranasal live attenuated influenza vaccine” NCT06609811 ↗ |
| Route | Intranasal | “intranasal live attenuated influenza vaccine” NCT06609811 ↗ |